PATENT CLAIM ANALYSIS

Application Number: 16020696
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "266220"]

Abstract:
Compounds of formula (I) or (II) can modulate the activity of S1P receptors.

Claim (Index 38):
The method of  claim 33 , wherein the compound is 1-((6-(trans-4-tert-butylcyclohexyloxy)quinolin-2-yl)methyl)piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13983489', '15644352', '14757822', '14417293', '14763893']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8518175430263027
- 35 USC 102 Novelty (BERT): 0.6207324304090576
- Combined Prediction Score: 0.8287090317645782
- Mean Citation Score: 537.610734
- Max Citation Score: 584.8409
- Similarity Product: 524.1739108173011

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test